Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

NCT00258960 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Liposomal Doxorubicin
DRUG: Cyclophosphamide
DRUG: Trastuzumab

Sponsor

Spanish Breast Cancer Research Group

Collaborators

[object Object]